“The medieval practice of bloodletting was based on the Moslem medical writers who emphasized revulsion (bleeding from a site located as far from the ailment as possible). This position was attacked in 1514 by Pierre Brissot (1478-1522), a Paris physician, who stressed the importance of bleeding near the locus of the disease (derivative bleeding). He was declared a medical heretic by the Paris Faculty of Medicine and derivative bleeding was forbidden by an act of the French parliament. In 1518, Brissot was exiled to Spain and Portugal. In 1539, the celebrated anatomist, Andreas Vesalius, continued the controversy with his famous Venesection Letter, which came to the support of Brissot“.
That venesection runs in the veins of our Pierre Brissot (former President of Bioiron and leading authority in hemochromatosis) may not come as a surprise to our members, but is the profession an hereditary trait or is that an atavistic feature of PR?….
In fact, Pierre Brissot is not only aware of his distinguished ancestry profession but also shared that information publically in his recently published historical article in the Revue du Praticien ( Vol. 67 _ Décembre 2017 ) titled “LA SAIGNÉE EN MÉDECINE : une très longue histoire qui n’est pas encore terminée” (“Bleeding in medicine: a very long story that is not over yet”).
Abstract submissions will close on the January 31, 2019. We will not be able to accept abstracts after this date.
As we have intentionally limited the number of invited lectures, there is a great opportunity for abstracts to be selected for oral presentations in the plenary and parallel sessions based on scientific quality. Thus, we want to encourage principle investigators and more junior researchers alike to submit abstracts.
Additionally, junior investigators who are members of the BioIron Society are able to apply for fellowships, including registration waivers and travel fellowships. These fellowship opportunities will be available during the registration/abstract submission process.
Please submit your abstracts covering exciting advances in iron biology – from the cell to the system, from very basic to the clinical, from mammalian to model organisms and microbial species.
Eighteen students will be selected from the list of qualified applicants and for at least nine of them the registration fees will be waived (reimbursed). The course will be held at EMBL training laboratories on May 2 – 4, 2019. All activities, materials and meals will be covered by the registration fee. Affordable accommodations will also be available. We encourage candidates to apply as early as possible. Looking forward to welcoming you all!
The Organizing Committee
Martina Muckenthaler, University of Heidelberg Matthias Hentze, EMBL, Heidelberg Ioav Cabantchik, President of the Bioiron Society